Molecular definition of breast tumor heterogeneity. [Cancer Cell. 2007] - PubMed

Related citations

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. [PLoS One. 2009]
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.
Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, et al. PLoS One. 2009 Dec 21; 4(12):e8377. Epub 2009 Dec 21.
Review Mammary stem cells and breast cancer--role of Notch signalling. [Stem Cell Rev. 2007]
Review Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G, Clarke RB. Stem Cell Rev. 2007 Jun; 3(2):169-75.
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. [J Clin Pathol. 2011]
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J. J Clin Pathol. 2011 Nov; 64(11):937-46. Epub 2011 Jun 16.
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. [Breast Cancer Res Treat. 2010]
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I. Breast Cancer Res Treat. 2010 Jul; 122(2):315-24. Epub 2009 Oct 1.
Review Breast cancer stem cells and intrinsic subtypes: controversies rage on. [Curr Stem Cell Res Ther. 2009]
Review Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H, Srour EF, Badve S. Curr Stem Cell Res Ther. 2009 Jan; 4(1):50-60.

See reviews... See all...

Cited by over 100 PubMed Central articles

Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives. [Am J Transl Res. 2011]
Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives.
Aalaoui-Jamali M, Bijian K, Batist G. Am J Transl Res. 2011; 3(5):434-44. Epub 2011 Sep 8.
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features. [BMC Med Genomics. 2011]
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.
Haakensen VD, Lingjaerde OC, Lüders T, Riis M, Prat A, Troester MA, Holmen MM, Frantzen JO, Romundstad L, Navjord D, et al. BMC Med Genomics. 2011 Nov 1; 4:77. Epub 2011 Nov 1.
The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. [PLoS One. 2011]
The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer.
Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA. PLoS One. 2011; 6(10):e26514. Epub 2011 Oct 20.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Molecular definition of breast tumor heterogeneity.
Molecular definition of breast tumor heterogeneity.
Cancer Cell. 2007 Mar ;11(3):259-73.

PubMed
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on sta...
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins.
Breast Cancer Res. 2010 ;12(2):R17. Epub 2010 Mar 5 .

PubMed
The prognostic significance of altered cyclin-dependent kinase inhibitors in hum...
The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.
Annu Rev Med. 1999 ;50:401-23.

PubMed
Serum proteomic analysis identifies a highly sensitive and specific discriminato...
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
Ann Surg Oncol. 2007 Sep ;14(9):2470-6. Epub 2007 Jun 27 .

PubMed
Gene expression profiling and histopathological characterization of triple-negat...
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Breast Cancer Res. 2007 ;9(5):R65.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Molecular definition of breast tumor heterogeneity.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Related citations

Cited by over 100 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information